News und Analysen
DGAP-News: Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2019
DGAP-News: Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2019
DGAP-News: Fresenius Medical Care published form 20-F for the fiscal year 2019
DGAP-News: Fresenius Medical Care published form 20-F for the fiscal year 2019
DGAP-News: Fresenius Medical Care erreicht Ziele für Geschäftsjahr 2019 und bestätigt Ausblick 2020 auf nachhaltiges profitables Wachstum
DGAP-News: Fresenius Medical Care erreicht Ziele für Geschäftsjahr 2019 und bestätigt Ausblick 2020 auf nachhaltiges profitables Wachstum
DGAP-News: Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
DGAP-News: Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.03.2020 in Weimar mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.03.2020 in Weimar mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-News: Successful start to fiscal year 2019/20 for Carl Zeiss Meditec with profitable growth
DGAP-News: Successful start to fiscal year 2019/20 for Carl Zeiss Meditec with profitable growth
DGAP-News: Carl Zeiss Meditec mit profitablem Wachstum erfolgreich ins Geschäftsjahr 2019/20 gestartet
DGAP-News: Carl Zeiss Meditec mit profitablem Wachstum erfolgreich ins Geschäftsjahr 2019/20 gestartet
DGAP-News: Carl Zeiss Meditec erzielt deutlichen Umsatz- und Ergebnisanstieg im Geschäftsjahr 2018/19
DGAP-News: Carl Zeiss Meditec erzielt deutlichen Umsatz- und Ergebnisanstieg im Geschäftsjahr 2018/19
DGAP-News: Carl Zeiss Meditec achieves significant increase in sales and earnings in fiscal year 2018/19
DGAP-News: Carl Zeiss Meditec achieves significant increase in sales and earnings in fiscal year 2018/19
DGAP-News: Fresenius Medical Care erweitert Vorstand mit Berufung von Global Chief Medical Officer Dr. Frank Maddux
DGAP-News: Fresenius Medical Care erweitert Vorstand mit Berufung von Global Chief Medical Officer Dr. Frank Maddux
DGAP-News: Fresenius Medical Care appoints Dr. Frank Maddux to Management Board, makes Global Chief Medical Officer a board position
DGAP-News: Fresenius Medical Care appoints Dr. Frank Maddux to Management Board, makes Global Chief Medical Officer a board position
DGAP-News: Fresenius Medical Care erzielt auch im dritten Quartal starkes organisches Wachstum
DGAP-News: Fresenius Medical Care erzielt auch im dritten Quartal starkes organisches Wachstum
DGAP-News: Fresenius Medical Care again delivers strong organic growth in the third quarter
DGAP-News: Fresenius Medical Care again delivers strong organic growth in the third quarter
DGAP-Adhoc: Carl Zeiss Meditec erzielt EBIT-Marge von 18,1% im Geschäftsjahr 2018/19
DGAP-Adhoc: Carl Zeiss Meditec erzielt EBIT-Marge von 18,1% im Geschäftsjahr 2018/19
DGAP-Adhoc: Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19
DGAP-Adhoc: Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19
This Recent FDA Approval Is Bad News for Pfizer
It's no secret why Pfizer (NYSE: PFE) stock has been struggling this year. Investors are worried about how well the company will be able to do in light of waning demand for its COVID-19 vaccine and
EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
Merck (MRK) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q1 2024 Earnings CallApr 25, 2024, 9:00 a.m. ET
Operator
Source Fool.com
Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.
In biopharma, it sometimes makes sense for companies to spend a lot of money on buying or developing technical capabilities that seem to be counterproductive at first glance. For instance, on April
2 Dividend Stocks to Buy and Hold Forever
Dividends can provide a steady stream of income to shareholders, but only if the dividend-paying company maintains or increases its payouts over the years. Unfortunately, not every dividend payer is
EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
On Monday, Keybanc analyst Scott Schoenhaus revised his price target on Recursion Pharmaceuticals (NASDAQ: RXRX) upward, opining the stock would climb by 33% and hit $16. The call came days after